Trial
NCT03852628
Kappa Opioid Receptor Antagonism for the Tx of AUD and Comorbid PTSD
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Pharmacotherapies for Alcohol and Substance Use Disorders Alliance
Collaborators
United States Department of Defense; RTI International
Condition
Post Traumatic Stress Disorder
Intervention
2mg Buprenex and 380mg Vivitrol
Why stopped
Futility analysis
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-09-14